The Effect of Galcanezumab-gnlm on Post-Traumatic, Migrainous Headaches
Clinical trial NCT06901518 · COMPLETED
Trial details
- NCT number
- NCT06901518
- Sponsor
- Albany Medical College
- Status
- COMPLETED
- Phase
- Phase 4
- Study type
- INTERVENTIONAL
- Start date
- 2020-08-10
- Primary completion
- 2024-06-30
- Enrollment
- 25
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.